Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 50INDUSTRY 4NETWORK 2OTHER_GOV 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Colorectal Neoplasms 1

Interventions

fludarabine phosphate 1fludarabine 1daratumumab 1carfilzomib 1Lenalidomide 1Dexamethasone 1Cyclophosphamide 1Azacitidine 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Neoplasms, Plasma Cell × Lenalidomide × Clear all
NCT04065789 2022-01-27

KyDaR

Tel-Aviv Sourasky Medical Center

Phase 2 Completed
41 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡